Beximco Pharma to manufacture molnupiravir for COVID-19
Pharma Times
JANUARY 20, 2022
The drug received conditional marketing authorisation in the UK from the MHRA in November
Sat.Jan 15, 2022 - Fri.Jan 21, 2022
153 
Billionaire-backed “rejuvenation” start-up Altos Labs launches operations
pharmaphorum
JANUARY 19, 2022
Just months after the venture was unveiled, controversial biotechnology company Altos Labs has officially launched with $3 billion in funding secured from investors. Dubbed an ‘anti-ageing’ company, Altos has gained mainstream attention for its focus on ‘rejuvenation’ and biological reprogramming technology. While the specific research goals have been kept a closely guarded secret, some scientists propose that rejuvenating cells in a lab could be a path to prolonging huma
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Will new Facebook ad policy shake up clinical trial recruitment?
Outsourcing Pharma
JANUARY 20, 2022
An expert from patient solutions firm Trialbee discusses how the social media firm's recent ban on targeted advertising might impact patient recruitment.
Four Big Implications for Patients and the Prescription Journey in 2022
Drug Channels
JANUARY 21, 2022
Today’s guest post comes from Chris Dowd, Senior Vice President of Market Development at ConnectiveRx. Chris discusses how COVID-19 is impacting stakeholders across the healthcare system, including patients, providers, pharmacies, and manufacturers. On February 22nd at 1:00 pm ET, ConnectiveRx will host Four Big Implications for Patients and the Prescription Journey in 2022 , a free webinar about the pandemic’s impact on key healthcare stakeholders.
Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Air of optimism surrounds lung cancer vaccine
Pharma Times
JANUARY 18, 2022
Cancer Research UK announces clinical trial for most common type of lung cancer
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
Europe launches initiative to transform clinical trials
Outsourcing Pharma
JANUARY 18, 2022
Regulatory bodies in the European Union have launched an initiative to develop the region as a focal point for clinical research and to better integrate clinical research in the European health system.
Five Takeaways from the Big Three PBMs’ 2022 Formulary Exclusions
Drug Channels
JANUARY 19, 2022
For 2022, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)— increased the number of drugs they excluded from their standard formularies. Each exclusion list contains 400 to 500 products. Growth in the number of excluded drugs slowed, due partly to the fact that so many drugs have already been dropped from PBMs’ formularies.
First-of-its-kind NHS gene pilot takes off
Pharma Times
JANUARY 18, 2022
The NHS launches world-first study investigating genetic testing for common diseases
CVS Health and Microsoft alliance: an example of an extended partnership
pharmaphorum
JANUARY 18, 2022
Microsoft and CVS Health have announced a new strategic alliance focusing on personalised care and accelerating digital transformation for the benefit of CVS customers and its employees. David Rhew, MD, global chief medical officer and VP of healthcare at Microsoft, tells us, “Using Microsoft technology, CVS Health will develop a more agile, digital-first technology foundation.” Digital innovation and implementation have skyrocketed within healthcare due to the need to adapt quickly
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
New patent for Bionpharma Inc drug NAPROXEN SODIUM
Drug Patent Watch
JANUARY 21, 2022
Annual Drug Patent Expirations for NAPROXEN+SODIUM Naproxen Sodium is a drug marketed by Bionpharma Inc, Catalent, Puracap Pharm Llc, Actavis Labs Fl Inc, Able, Amneal Pharms Ny, Aurobindo Pharma Ltd,…. The post New patent for Bionpharma Inc drug NAPROXEN SODIUM appeared first on DrugPatentWatch - Make Better Decisions.
NEW: The Drug Channels 2022 Video Webinar Series
Drug Channels
JANUARY 18, 2022
Join Dr. Adam J. Fein, CEO of Drug Channels Institute (DCI), for three live video webinars during 2022. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. Click here to order the Drug Channels 2022 Video Webinar Series. During these events, Dr. Fein will address the latest issues confronting the U.S. drug channel.
Scandi pharma: Swede deal for Psyros Diagnostics
Pharma Times
JANUARY 21, 2022
Psyros Diagnostics has signed an agreement to be acquired by the Swedish company, Prolight Diagnostics AB. Psyros’s ground-breaking Point-of-Care (POC) technology enables the measurement of disease-indicating molecules in extremely low concentrations–in ten minutes or less.
GSK rejects $68.4bn Unilever bid for consumer health
pharmaphorum
JANUARY 17, 2022
GlaxoSmithKline (GSK) claims it has rejected three unsolicited, conditional and non-binding proposals from Unilever to acquire GSK Consumer Healthcare in a deal worth approximately $68.4 billion (£50 billion). The Consumer Healthcare business is a Joint Venture between GSK and Pfizer, with GSK holding a majority controlling interest of 68% and Pfizer 32%.
Why Every Small Business Needs an HCM Solution: A Comprehensive Guide
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Detainees Sue Arkansas Jail That Gave Them Ivermectin to Treat Covid
NY Times
JANUARY 17, 2022
For months, the jail’s doctor has promoted the drug, which health experts say should not be used to treat or prevent Covid-19.
Which pharmaceutical drugs have the most drug patents in Mexico?
Drug Patent Watch
JANUARY 16, 2022
This chart shows the drugs with the most patents in Mexico. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Mexico? appeared first on DrugPatentWatch - Make Better Decisions.
NICE moves: increased accessibility and flexibility for health tech
Pharma Times
JANUARY 19, 2022
NICE also aims to make strides in digital, genomic and antimicrobial technologies
Two new drugs added to WHO list of COVID-19 therapies
pharmaphorum
JANUARY 17, 2022
A World Health Organization (WHO) panel has given the green light to two new drugs to treat COVID-19. US-based Eli Lilly’s baricitinib (Olumiant), a Janus kinase inhibitor, and GlaxoSmithKline and Vir Biotechnology’s sotrovimab, a monoclonal antibody, were recommended in new WHO guidelines, published in the British Medical Journal. . Baricitinib, administered with corticosteroids, was strongly recommended as a treatment for patients with severe or critical illness.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Searching for Pfizer’s Paxlovid Pills When Mom Got Covid
NY Times
JANUARY 19, 2022
The experience showed how hard it is for many people to get potentially lifesaving treatments.
ililli: How Social Audio is Driving HCP Engagement
Pharma Marketing Network
JANUARY 19, 2022
Talk to me. Pharma brands that want deep engagements need to look at and listen to social audio. It’s not surprising. In fact, it’s the most direct route to your goal. You want to talk to doctors? To start the conversation, we put pictures in front of them, bombarded them with videos, retarget them, and then send them emails. We want to talk, and they want to listen.
New AstraZeneca treatment for rare cancer reduces risk of death
Pharma Times
JANUARY 19, 2022
Imfinzi has shown improvements in the overall survival of patients with biliary tract cancer
Covid vaccine booster raises antibody levels in fight against Omicron
pharmaphorum
JANUARY 21, 2022
A third dose of vaccine has been shown to effectively neutralise the Omicron variant of covid-19, according to researchers. Research led by UCLH, UCL and the Francis Crick Institute found that the booster dose successfully stimulates antibody levels that neutralise Omicron. Details of the study were published in The Lancet this week. UCLH researchers stated that antibodies generated in people who had received only two doses of either the Oxford/AstraZeneca vaccine or the Pfizer/BioNTech vaccin
Best Practices to Streamline Compensation Management: A Foundation for Growth
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Which pharmaceutical companies have the most granule dosed drugs?
Drug Patent Watch
JANUARY 17, 2022
This chart shows the pharmaceutical companies with the most granule dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most granule dosed drugs…. The post Which pharmaceutical companies have the most granule dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
Pfizer: COVID-19 treatment shows promise against omicron variant
Outsourcing Pharma
JANUARY 18, 2022
The pharmaceutical company reports studies have demonstrated the main protease inhibitor of Paxlovid maintains in vitro efficiency against the variant.
Pharmacist vacancies highlight need for funding booster
Pharma Times
JANUARY 21, 2022
New figures from Health Education England (HEE) show that the pharmacist vacancy rate in community pharmacies across England has doubled to 8% between 2017 and 2021.
Gilead takes legal action against counterfeit HIV drug network
pharmaphorum
JANUARY 20, 2022
US pharma giant Gilead Sciences has accused a network of unauthorised suppliers and distributors of selling more than $250 million of counterfeit versions of its HIV medications. According to the company, the defendants reportedly sold 85,247 bottles of medicine with counterfeit Gilead labelling to pharmacies over a two-year period, using falsified supply chain documentation to conceal their origin.
Enhance Healthcare Efficiency With Top Payroll & HCM Services
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Let's personalize your content